Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study.

Authors :: Papi A
Chipps BE
Beasley R
Panettieri RA Jr
Israel E
Cooper M
Dunsire L
Jeynes-Ellis A
Rees R
Albers FC
Cappelletti C
Source :: Therapeutic advances in respiratory disease [Ther Adv Respir Dis] 2024 Jan-Dec; Vol. 18, pp. 17534666241232264.
Publication Year :: 2024
Abstract: What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol-budesonide , AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.

Subjects :: Humans
Administration, Inhalation
Adult
Middle Aged
Male
Female
Treatment Outcome
Adolescent
Young Adult
Aged
Anti-Asthmatic Agents administration & dosage
Asthma drug therapy
Albuterol administration & dosage
Drug Combinations
Bronchodilator Agents administration & dosage
Budesonide administration & dosage
Nebulizers and Vaporizers

Full Text Access

Tools